Dr Jenny Kinane, Ms Islay Mowatt, Dr Carolyn Clark, Dr Gunashree Nagaraju
1Capital and Coast DHB, , New Zealand
Biography:
Bio to come
Abstract:
Introduction:
Renal transplantation provides the best survival and quality of life among kidney replacement therapies. Reducing time on dialysis before transplant improves health outcomes. The ANZSN have established transplantation waitlisting as a key performance indicator evaluating those who are transplanted or waitlisted within 6 months of Kidney Replacement Therapy start. This review evaluates our performance in listing suitable transplant candidates in the greater Wellington area within six months. We compared data from 2017 and 2022 as this 5 year gap encompassed significant disruptions including the COVID-19 pandemic, staff shortages, and resource limitations, potentially influencing patient outcomes.
Methodology:
Using our local database of incident dialysis patients in 2017 and 2022, we identified those placed on the deceased donor transplant waitlist. For each patient, we assessed the time from the initiation of KRT to listing, and whether it took more or less than six months. Additionally, we collected data on ethnicity, sex and post-code to examine potential inequities in the listing process.
Results:
In 2017, 54 patients started KRT, with 37% (20) waitlisted for deceased donor transplantation. Of these, 65% were listed within six months. In 2022, 82 patients started KRT, with 30.5% (25) waitlisted; 60% were listed within six months.
Conclusion:
This study highlights the impact of systemic challenges such as the COVID-19 pandemic, staffing and resource limitations on transplant listing timelines. The decrease in timely listings in 2022 may reflects these disruptions, underscoring the need to address healthcare constraints to ensure timely access to transplantation for RRT patients